• Home
  • About
  • Expertise
  • Services
  • Contact
  • More
    • Home
    • About
    • Expertise
    • Services
    • Contact
  • Home
  • About
  • Expertise
  • Services
  • Contact

Services

Preclinical drug development consulting

Preclinical drug development consulting

Preclinical drug development consulting

  • Comprehensive End-to-End Preclinical Expertise: Providing strategic consultancy across the full preclinical drug development process, from concept to IND/CTA readiness. 


  • Rational Study Design: Designing robust preclinical pharmacology, PK, and toxicology studies that meet regulatory expectations and strengthen investor confidence.
     
  • GLP and

  • Comprehensive End-to-End Preclinical Expertise: Providing strategic consultancy across the full preclinical drug development process, from concept to IND/CTA readiness. 


  • Rational Study Design: Designing robust preclinical pharmacology, PK, and toxicology studies that meet regulatory expectations and strengthen investor confidence.
     
  • GLP and Non-GLP Study Oversight: Designing and reviewing both GLP and non-GLP studies to ensure scientific rigor, regulatory alignment, and a clear path toward successful clinical entry.




More info

Regulatory development support

Preclinical drug development consulting

Preclinical drug development consulting

  • Preclinical Planning & Alignment: Designing and aligning preclinical study plans to meet regulatory expectations and support a seamless transition toward clinical development.
     
  • Regulatory Pathway Guidance: Navigating complex preclinical/ regulatory requirements, reducing barriers and smoothing the path to first-in-human clinical studies.

  • Preclinical Planning & Alignment: Designing and aligning preclinical study plans to meet regulatory expectations and support a seamless transition toward clinical development.
     
  • Regulatory Pathway Guidance: Navigating complex preclinical/ regulatory requirements, reducing barriers and smoothing the path to first-in-human clinical studies.
     
  • Regulatory Documentation Support: Reviewing and supporting the preclincial preparation of key regulatory submissions (e.g., IND, CTA) to ensure readiness and increase the likelihood of approval for clinical investigation.



More info

Target product profile (TPP) support

Preclinical drug development consulting

Target product profile (TPP) support

  • Strategic TPP Creation: Developing comprehensive TPPs to guide program strategy, clarify development objectives, and ensure alignment across all stakeholders.
     
  • Customizable TPP Templates: Providing a structured, easy-to-use TPP template tailored to the needs of the customer, from early-stage up to late-stage development programs.
     
  • Ongoing

  • Strategic TPP Creation: Developing comprehensive TPPs to guide program strategy, clarify development objectives, and ensure alignment across all stakeholders.
     
  • Customizable TPP Templates: Providing a structured, easy-to-use TPP template tailored to the needs of the customer, from early-stage up to late-stage development programs.
     
  • Ongoing TPP Support: From initial drafting to refinement, I help complete and maintain your TPP as a central roadmap for clinical development, regulatory planning, and commercialization.




More info

Preclinical drug development consulting

Discovery and early research

Discovery and early research

Discovery and early research

Establish biolgical rationale for target and models relevant to the human disease for:

  • Target identification & validation
  • Hit identification & screening
  • Lead selection & optimization
  • Candidate selection

In vitro pharmacology

Discovery and early research

Discovery and early research

Demonstrate reproducible pharmacologic activity (e.g. potency, selectivity and biomarker assays) in relevant in vitro models that support the proposed mechanism of action.

In vivo pharmacology

Discovery and early research

Pharmacokinetic & ADME

Assess drug’s intended pharmacological effects in vivo, including dose response, biomarkers, PK/PD relationship and relevant endpoints to evaluate to the pharmacological effect in the tissue of interest.

Pharmacokinetic & ADME

Pharmacokinetic & ADME

Pharmacokinetic & ADME

Characterize pharmacokinetics, absorption, distribution, metabolism, and excretion (ADME) to define exposure–response relationships and guide first-in-human (FIH) dose selection.

Non-GLP safety

Pharmacokinetic & ADME

Non-GLP safety

Include in vitro and, where needed, in vivo assays  to assess potential mutagenic and clastogenic risks (genotox).

  

Perform core battery studies (CNS, cardiovascular, respiratory) to evaluate potential acute functional effects on vital organ systems.


GLP safety

Pharmacokinetic & ADME

Non-GLP safety

Repeat-dose & chronic toxicity studies in relevant species to identify target organ toxicities and establish safety margins, supporting the IND package.

  

Characterize ocular/systemic exposure in toxicity studies to  enable safe clinical starting dose estimation.

What regulators look for in preclincial data package?

Mechanistic rationale

Mechanistic rationale

Mechanistic rationale

Demonstrate a clear understanding of the drug’s mode of action (MoA) and underlying biological rationale.

Relevance of model

Mechanistic rationale

Mechanistic rationale

Use disease models that closely replicate human pathophysiology to ensure meaningful and translatable results.

Reproducibility

Mechanistic rationale

Reproducibility

Ensure consistent results across studies using validated methods and standardized SOPs. 

Tracebility

Transparency

Reproducibility

Link raw data to reports and summary tables, providing a clear audit trail for IND submission. 

Transparency

Transparency

Transparency

Document all data thoroughly, ensuring traceability and controlled collection. Reports should support future IND submissions, clearly outlining methods, deviations, and limitations to maintain scientific defensibility. 


Target Product Profile (TPP) support

What is a TPP?

What is a TPP?

What is a TPP?

  • A strategic roadmap outlining key product characteristics
     
  • Summarizes a drug development program, detailing the ideal profile of a drug at the time of approval
     
  • Serves as a living guide for teams from discovery to commercialization

Purpose

What is a TPP?

What is a TPP?

  • Bridges early development with regulatory goals, shaping formulation, nonclinical, and clinical planning
     
  • Aligns scientific innovation with clinical, regulatory, and commercial objectives
     
  • Acts as a blueprint for development strategies and go-to-market decisions



Core content

What is a TPP?

Core content

  • Insights from all key disciplines: preclinical, CMC, clinical, and statistical teams
     
  • Target indication and patient population
     
  • Efficacy and safety profile
     
  • Competitive differentiation
     
  • Regulatory pathways and labeling goals

Copyright © 2025 OcuRes Consult - All Rights Reserved.

  • Home

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept